NED-260

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNED-260
Drug Alias NameNED-260
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitorsInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNed Biosystems
China Registration ClassN/A

Develop Information

Active CompaniesNed Biosystems
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A